Published in Cancer Weekly, September 8th, 2009
"Each sample was evaluated with toluidine blue-stained wet films as benign, suspicions or malignant, and the diagnoses were compared to results Of conventional smears and cell blocks. The sensitivity, specificity, positive predictive value and negative predictive value of wetfilms were determined. Of 179 samples, toluidine blue stains from 18...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2009-09-08)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.